Screening technologies for small molecule discovery: the state of the art.

[1]  R. Clegg.  Fluorescence resonance energy transfer. , 2020, Current opinion in biotechnology.

[2]  D. Beebe,et al.  The present and future role of microfluidics in biomedical research , 2014, Nature.

[3]  Thierry Kogej,et al.  Big pharma screening collections: more of the same or unique libraries? The AstraZeneca-Bayer Pharma AG case. , 2013, Drug discovery today.

[4]  C. Austin,et al.  Improving the Human Hazard Characterization of Chemicals: A Tox21 Update , 2013, Environmental health perspectives.

[5]  M. Busch,et al.  Does Your Lab Coat Fit to Your Assay? , 2013, Journal of biomolecular screening.

[6]  Asher Mullard,et al.  European Lead Factory opens for business , 2013, Nature Reviews Drug Discovery.

[7]  Andrew Bell,et al.  Shaping a Screening File for Maximal Lead Discovery Efficiency and Effectiveness: Elimination of Molecular Redundancy , 2012, J. Chem. Inf. Model..

[8]  Michael Gray,et al.  Solid Sample Weighing and Distribution , 2012 .

[9]  J. Havel,et al.  Chemical Genomics: Time-Resolved Fluorescence Resonance Energy Transfer Technologies in HTS , 2012 .

[10]  Maria F. Sassano,et al.  Discovery of β-Arrestin–Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy , 2011, Proceedings of the National Academy of Sciences.

[11]  Chad Quinn,et al.  Compound Management: Guidelines for Compound Storage, Provision, and Quality Control , 2011, Current protocols in chemical biology.

[12]  C. Harris,et al.  The Design and Application of Target-Focused Compound Libraries , 2011, Combinatorial chemistry & high throughput screening.

[13]  Florian Nigsch,et al.  Recent trends and observations in the design of high-quality screening collections. , 2011, Future medicinal chemistry.

[14]  N. Ito,et al.  Fluorescence-quenching screening of protein kinase C ligands with an environmentally sensitive fluorophore. , 2011, Bioconjugate chemistry.

[15]  D. Bojanic,et al.  Impact of high-throughput screening in biomedical research , 2011, Nature Reviews Drug Discovery.

[16]  Christopher B. Black,et al.  Cell-based screening using high-throughput flow cytometry. , 2011, Assay and drug development technologies.

[17]  S. Frye,et al.  Accessing protein methyltransferase and demethylase enzymology using microfluidic capillary electrophoresis. , 2010, Chemistry & biology.

[18]  Ricardo Macarron,et al.  Enhancements of screening collections to address areas of unmet medical need: an industry perspective. , 2010, Current opinion in chemical biology.

[19]  Charles C. Persinger,et al.  How to improve R&D productivity: the pharmaceutical industry's grand challenge , 2010, Nature Reviews Drug Discovery.

[20]  Stephen V Frye,et al.  The art of the chemical probe. , 2010, Nature chemical biology.

[21]  Christopher P Austin,et al.  Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease. , 2010, Journal of medicinal chemistry.

[22]  Tim J. Wigle,et al.  Screening for Inhibitors of Low-Affinity Epigenetic Peptide-Protein Interactions: An AlphaScreen™-Based Assay for Antagonists of Methyl-Lysine Binding Proteins , 2010, Journal of biomolecular screening.

[23]  J. Zock,et al.  Applications of High Content Screening in Life Science Research , 2009, Combinatorial chemistry & high throughput screening.

[24]  Yanli Wang,et al.  PubChem: a public information system for analyzing bioactivities of small molecules , 2009, Nucleic Acids Res..

[25]  William P. Janzen,et al.  Review: Advances in Improving the Quality and Flexibility of Compound Management , 2009, Journal of biomolecular screening.

[26]  E. Trinquet,et al.  HTRF: A Technology Tailored for Drug Discovery –A Review of Theoretical Aspects and Recent Applications , 2009, Current chemical genomics.

[27]  M. Bielefeld-Sévigny.  AlphaLISA immunoassay platform- the "no-wash" high-throughput alternative to ELISA. , 2009, Assay and drug development technologies.

[28]  C. Tautermann,et al.  G-protein-coupled receptor-focused drug discovery using a target class platform approach. , 2009, Drug discovery today.

[29]  Irini Akritopoulou-Zanze,et al.  Kinase-targeted libraries: the design and synthesis of novel, potent, and selective kinase inhibitors. , 2009, Drug discovery today.

[30]  J. McCarter,et al.  High-throughput assays for sirtuin enzymes: a microfluidic mobility shift assay and a bioluminescence assay. , 2008, Analytical biochemistry.

[31]  Sam Michael,et al.  Compound Management for Quantitative High-Throughput Screening , 2008, JALA.

[32]  Ruili Huang,et al.  Fluorescence spectroscopic profiling of compound libraries. , 2008, Journal of medicinal chemistry.

[33]  Michael C. Myers,et al.  HTS identifies novel and specific uncompetitive inhibitors of the two-component NS2B-NS3 proteinase of West Nile virus. , 2007, Assay and drug development technologies.

[34]  William P. Janzen,et al.  A Chemogenomic Analysis of the Human Proteome: Application to Enzyme Families , 2007, Journal of biomolecular screening.

[35]  Mark B. Carter,et al.  Flow cytometry for drug discovery, receptor pharmacology and high-throughput screening. , 2007, Current opinion in pharmacology.

[36]  D. Pereira,et al.  Origin and evolution of high throughput screening , 2007, British journal of pharmacology.

[37]  D. Rognan.  Chemogenomic approaches to rational drug design , 2007, British journal of pharmacology.

[38]  J. Violin,et al.  β-Arrestin-biased ligands at seven-transmembrane receptors , 2007 .

[39]  C. Parker,et al.  Recommendations for the reduction of compound artifacts in time-resolved fluorescence resonance energy transfer assays. , 2007, Assay and drug development technologies.

[40]  S. Michnick,et al.  Application of protein-fragment complementation assays in cell biology. , 2007, BioTechniques.

[41]  D. Chang,et al.  A high throughput drug screen based on fluorescence resonance energy transfer (FRET) for anticancer activity of compounds from herbal medicine , 2007, British journal of pharmacology.

[42]  R. Neubig,et al.  Identification of Small-Molecule Inhibitors of RGS4 Using a High-Throughput Flow Cytometry Protein Interaction Assay , 2007, Molecular Pharmacology.

[43]  Matthew A Cooper,et al.  Optical biosensors: where next and how soon? , 2006, Drug discovery today.

[44]  E. Snapp,et al.  Rational Design and Evaluation of FRET Experiments to Measure Protein Proximities in Cells , 2006, Current protocols in cell biology.

[45]  S. Doberstein,et al.  HTS technologies in biopharmaceutical discovery. , 2006, Drug discovery today.

[46]  Garry P Nolan,et al.  Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling , 2006, Nature Methods.

[47]  Claudio N. Cavasotto,et al.  Structure-based development of target-specific compound libraries. , 2006, Drug discovery today.

[48]  Zhan Deng,et al.  Knowledge-based design of target-focused libraries using protein-ligand interaction constraints. , 2006, Journal of medicinal chemistry.

[49]  Klaus Stenzel,et al.  High‐Throughput Screening in Agrochemical Research , 2005 .

[50]  P. Cleveland,et al.  Nanoliter dispensing for uHTS using pin tools. , 2005, Assay and drug development technologies.

[51]  Peter Meier,et al.  Key aspects of the Novartis compound collection enhancement project for the compilation of a comprehensive chemogenomics drug discovery screening collection. , 2005, Current topics in medicinal chemistry.

[52]  T. Insel,et al.  NIH Molecular Libraries Initiative , 2004, Science.

[53]  Xueliang Fang,et al.  Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization. , 2004, Analytical biochemistry.

[54]  Susanne Wilhelm,et al.  Ultra-high-throughput screening based on cell-surface display and fluorescence-activated cell sorting for the identification of novel biocatalysts. , 2004, Current opinion in biotechnology.

[55]  Tudor I. Oprea,et al.  Flow cytometry for high-throughput, high-content screening. , 2004, Current opinion in chemical biology.

[56]  Randy Hoffman,et al.  Overcoming compound interference in fluorescence polarization-based kinase assays using far-red tracers. , 2004, Assay and drug development technologies.

[57]  Richard N. Ellson,et al.  Transfer of low nanoliter volumes between microplates using focused acoustics-automation considerations , 2003 .

[58]  D. L. Taylor,et al.  Advances in high content screening for drug discovery. , 2003, Assay and drug development technologies.

[59]  Hans-Joachim Böhm,et al.  A guide to drug discovery: Hit and lead generation: beyond high-throughput screening , 2003, Nature Reviews Drug Discovery.

[60]  J. Sportsman,et al.  A Homogeneous Fluorescence Polarization Assay Adaptable for a Range of Protein Serine/Threonine and Tyrosine Kinases , 2003, Journal of biomolecular screening.

[61]  R. Eglen.  Enzyme fragment complementation: a flexible high throughput screening assay technology. , 2002, Assay and drug development technologies.

[62]  Michael Johnson,et al.  Converting a Protease Assay to a Caliper® Format LabChip System: , 2002 .

[63]  H. Blau,et al.  Protein–protein interactions monitored in mammalian cells via complementation of β-lactamase enzyme fragments , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[64]  H. Bazin,et al.  Homogeneous time resolved fluorescence resonance energy transfer using rare earth cryptates as a tool for probing molecular interactions in biology. , 2001, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[65]  S. Henikoff,et al.  High-throughput screening for induced point mutations. , 2001, Plant physiology.

[66]  M. Budarf,et al.  Homogeneous assays for single-nucleotide polymorphism typing using AlphaScreen. , 2001, Genome research.

[67]  Gregory J. Parker,et al.  Development of High Throughput Screening Assays Using Fluorescence Polarization: Nuclear Receptor-Ligand-Binding and Kinase/Phosphatase Assays , 2000, Journal of biomolecular screening.

[68]  I. Johnson,et al.  Chemical and physiological characterization of fluo-4 Ca(2+)-indicator dyes. , 2000, Cell calcium.

[69]  P. Negulescu,et al.  Intracellular detection assays for high-throughput screening. , 1998, Current opinion in biotechnology.

[70]  S. M. Ridley,et al.  High‐throughput screening as a tool for agrochemical discovery: automated synthesis, compound input, assay design and process management , 1998 .

[71]  S H Kim,et al.  Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. , 1998, Science.

[72]  Selim M. Senkan,et al.  High-throughput screening of solid-state catalyst libraries , 1998, Nature.

[73]  R A Mathies,et al.  Capillary electrophoresis chips with integrated electrochemical detection. , 1998, Analytical chemistry.

[74]  R. Haugland,et al.  Quenched BODIPY dye-labeled casein substrates for the assay of protease activity by direct fluorescence measurement. , 1997, Analytical biochemistry.

[75]  R Y Tsien,et al.  Improved indicators of cell membrane potential that use fluorescence resonance energy transfer. , 1997, Chemistry & biology.

[76]  Neil D. Cook,et al.  Scintillation proximity assay: a versatile high-throughput screening technology , 1996 .

[77]  B. Neagle,et al.  FLIPR: A New Instrument for Accurate, High Throughput Optical Screening , 1996 .

[78]  R. Tsien,et al.  Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer , 1996, Current Biology.

[79]  M. Jolley.  Fluorescence Polarization Assays for the Detection of Proteases and Their Inhibitors , 1996 .

[80]  W. Checovich,et al.  Fluorescence polarization — a new tool for cell and molecular biology , 1995, Nature.

[81]  R Y Tsien,et al.  Wavelength mutations and posttranslational autoxidation of green fluorescent protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[82]  W. Checovich,et al.  A new protease activity assay using fluorescence polarization. , 1994, BioTechniques.

[83]  Walter Sneader,et al.  Drug Discovery: The Evolution of Modern Medicines , 1985 .

[84]  A. Fleming,et al.  On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzæ , 1929 .

[85]  A. Aulabaugh,et al.  Application of Fluorescence Polarization in HTS Assays. , 2016, Methods in molecular biology.

[86]  H. Fu,et al.  Chemical Genomics: Label-Free Biosensor Technologies in Small Molecule Modulator Discovery , 2012 .

[87]  Daniela Gabriel.  Screening When High Content Screening meets High Throughput , 2012 .

[88]  Mark Warne,et al.  Informatics in compound library management. , 2009, Methods in molecular biology.

[89]  W. Janzen,et al.  High-throughput screening of the cyclic AMP-dependent protein kinase (PKA) using the caliper microfluidic platform. , 2009, Methods in molecular biology.

[90]  Mindy I. Davis,et al.  A quantitative analysis of kinase inhibitor selectivity , 2008, Nature Biotechnology.

[91]  K. Giuliano,et al.  High Content Screening , 2006, Methods in Molecular Biology.

[92]  O. J. Trask,et al.  Assay Guidance Manual , 2004 .

[93]  James A Chan,et al.  Compound library management. , 2002, Methods in molecular biology.

[94]  Anne R. Kopf-Sill,et al.  Commercializing Lab-on-a-Chip Technology , 2000 .

[95]  G. Zlokarnik.  [15] Fusions to β-lactamase as a reporter for gene expression in live mammalian cells , 2000 .

[96]  Hossein Salimi-Moosavi,et al.  Biology Lab-on-a Chip for Drug Screening , 1998 .

[97]  R. Mitra,et al.  Fluorescence resonance energy transfer between blue-emitting and red-shifted excitation derivatives of the green fluorescent protein. , 1996, Gene.

[98]  大野 耐一,et al.  Just-in-time for today and tomorrow , 1988 .